Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/28/2010US20100272717 Combinations of therapeutic agents for treating cancer
10/28/2010US20100272713 Genetic Markers Associated with Endometriosis and Use Thereof
10/28/2010US20100272712 Jnk3 as a target for the treatment of angiogenesis-related diseases
10/28/2010US20100272711 Compositions and methods for the treatment and prevention of cardiovascular diseases
10/28/2010US20100272710 Compositions and methods for treating and preventing aging-associated diseases
10/28/2010US20100272709 Cathepsin l mediated diseases and associated methods and products
10/28/2010US20100272706 Antivirals
10/28/2010US20100272702 Methods and compositions for treating neuropathies
10/28/2010US20100272688 Method of treating or retarding the development of blindness
10/28/2010US20100272683 Heterocyclylaminoalkyl substituted benzimidazoles
10/28/2010US20100272682 Method for improving pharmacokinetics
10/28/2010US20100272681 Inhibitors of Serine Proteases
10/28/2010US20100272680 Piperidinyl Cyclic Amido Antiviral Agents
10/28/2010US20100272678 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010US20100272674 Hepatitis C Virus Inhibitors
10/28/2010US20100272673 Ionomeric Silicone Thermoplastic Elastomers
10/28/2010US20100272672 Crosslinked hydrogels
10/28/2010US20100272671 Co-Therapy For Diabetic Conditions
10/28/2010US20100272670 Biodegradable polyanhydrides with natural bioactive molecules
10/28/2010US20100272669 Freeze-Dried Composition
10/28/2010US20100272663 Cosmetic composition including an anhydrous gel and a glyceryl ester
10/28/2010US20100272660 Cosmetic or pharmaceutical composition comprising a polycondensate, the said polycondensate and method of cosmetic treatment
10/28/2010US20100272655 Menthylcarboxamides and Their Use as Cooling Agents
10/28/2010US20100272654 Levalbuterol salt
10/28/2010US20100272645 Myocardial perfusion imaging method
10/28/2010US20100272642 Pet probe having an alkoxy group substituted by fluorine and hydroxy group
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010US20100269858 Compositions and kits for the removal of irritating compounds from bodily surfaces
10/28/2010US20100269825 Inhalation particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1h)-quinolinone and a corticosteroid
10/28/2010DE4124468B4 Verfahren zur Gewinnung eines Polylactids in gereinigtem Zustand sowie ein Verfahren zur Herstellung einer pharmazeutischen Zusammensetzung mit den gereinigten Polylactiden A process for obtaining a polylactide in a purified state and a process for preparing a pharmaceutical composition comprising the purified polylactides
10/28/2010DE202009012983U1 Neue therapeutische Konzepte für die Behandlung von Fibromyalgien New therapeutic approaches for the treatment of fibromyalgia
10/28/2010DE102009018537A1 Verwendung von mit Chinazolinon-Derivat oberflächen-modifizierten Silikonformkörpern Use of quinazolinone derivative with surface-modified silicone moldings
10/28/2010DE102009018334A1 Verwendung von Glycyrrhetinsäure und/oder Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der heuteigenen DNA Use of glycyrrhetinic acid and / or derivatives for the preparation of cosmetic or dermatological preparations for the prevention of damage to the skin's DNA and / or repair damage already occurred at the today's DNA
10/28/2010CA2791947A1 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
10/28/2010CA2761108A1 Heterocyclic compounds as mek inhibitors
10/28/2010CA2759929A1 Use of guanethidine for treating hypertension by local vascular delivery
10/28/2010CA2759874A1 Methods of treating a pulmonary bacterial infection using fluoroquinolones
10/28/2010CA2759870A1 Particulate pharmaceutical composition with an opioid and an opioid antagonist
10/28/2010CA2759821A1 Compositions and methods for treatment of cardiovascular disease
10/28/2010CA2759793A1 Preparation and application of the new antibacterial and anticancer compounds and their derivatives
10/28/2010CA2759730A1 Stable topical compositions for 1,2,4-thiadiazole derivatives
10/28/2010CA2759724A1 Methods of treatment for solid tumors
10/28/2010CA2759723A1 Colon lavage system
10/28/2010CA2759714A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759713A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759706A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759697A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759690A1 Carboxylic acid compound
10/28/2010CA2759679A1 Novel compound amycolamicin, method for production thereof, and use thereof
10/28/2010CA2759655A1 Heteroaryl compounds and uses thereof
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759614A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759607A1 Modulators of 5-ht receptors and methods of use thereof
10/28/2010CA2759604A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759597A1 Method for the treatment of acute myeloid leukemia
10/28/2010CA2759595A1 Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer
10/28/2010CA2759571A1 Two component interactive emulsion product
10/28/2010CA2759547A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759505A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759501A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759474A1 Prodrugs based on gemcitabine structure and synthetic methods and applications thereof
10/28/2010CA2759456A1 Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
10/28/2010CA2759442A1 Galactooligosaccharide for use in prevention of intestinal inflammatory disorder
10/28/2010CA2759397A1 Improved method of achieving and maintaining a specified alkylene oxide production parameter with a high efficiency catalyst
10/28/2010CA2759368A1 5-alkynyl-pyridines
10/28/2010CA2759364A1 Thioxanthene derivatives for the treatment of infectious diseases
10/28/2010CA2759354A1 Method of treating or preventing a convulsive disorder in a patient in need thereof
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2759244A1 Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
10/28/2010CA2759241A1 Novel anti-inflammatory agents
10/28/2010CA2759181A1 Innate immune suppression enables repeated delivery of long rna molecules
10/28/2010CA2759160A1 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010CA2759142A1 Diaryl ethers
10/28/2010CA2759131A1 Novel 7-deazapurine nucleosides for therapeutic uses
10/28/2010CA2759129A1 Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
10/28/2010CA2759127A1 A novel formulation of meloxicam
10/28/2010CA2759125A1 A novel formulation of indomethacin
10/28/2010CA2759123A1 A novel formulation of diclofenac
10/28/2010CA2759122A1 A novel formulation of naproxen
10/28/2010CA2759113A1 A novel formulation of metaxalone
10/28/2010CA2759109A1 Method for the production of commercial nanoparticle and microparticle powders
10/28/2010CA2759104A1 Method for improving the dissolution profile of a biologically active material
10/28/2010CA2759041A1 Agglomerate formulations useful in dry powder inhalers
10/28/2010CA2758985A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758976A1 Chemosensory receptor ligand-based therapies
10/28/2010CA2758968A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2758838A1 Heterocyclic antiviral compounds
10/28/2010CA2758731A1 2-alkyl piperidine mglur5 receptor modulators
10/28/2010CA2758729A1 Arylsulfonamide ccr3 antagonists
10/28/2010CA2758644A1 Methods for improving pharmacokinetics
10/28/2010CA2758640A1 3,3'-spiroindolinone derivatives and their use for cancer
10/28/2010CA2758505A1 Diamide compounds having muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activity
10/28/2010CA2757866A1 Novel amide and amidine derivatives and uses thereof
10/28/2010CA2757764A1 Cancer antigen helper peptide
10/28/2010CA2756925A1 Sublingual spray formulation comprising dihydroartemesinin
10/28/2010CA2756879A1 Sublingual pharmaceutical composition comprising a neutral oil
10/28/2010CA2756876A1 A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
10/28/2010CA2756654A1 Thiazole derivatives and their use as p2y12 receptor antagonists
1 ... 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 ... 7860